Oaknin A, Pothuri B, Gilbert L, Sabatier R, et al. Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study. Clin Cancer Res 2023 Jun 26:CCR-22-3915. doi: 10.1158/1078-0432.CCR-22-3915.
PMID: 37363992